Medicare Enrolled
Dr. Michael Dicus, MD
Nephrology · Salinas, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dicus from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dicus?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dicus
Dr. Michael Dicus is a nephrology specialist in Salinas, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dicus performed 18,906 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Dicus received a total of $8,400 from 39 pharmaceutical and/or device companies across 478 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dicus is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 1% volume in CA
$8,400 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗18,906
Medicare services
Top 1% in CA for nephrology
Not available
Unique patients (not deduplicated)
$20
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
9,180 | $0 | $2 |
| Romosozumab injection (Evenity) for osteoporosis | 3,990 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 2,040 | $18 | $35 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
960 | $6 | $18 |
| Dialysis services for patients 20 or older Dialysis treatment provided to patients aged 20 years or older, involving four or more physician visits per month. |
597 | $295 | $480 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
374 | $44 | $150 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
337 | $65 | $105 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
156 | $12 | $40 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
131 | $8 | $11 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
120 | $63 | $209 |
| Kidney function blood test panel | 111 | $9 | $30 |
| Dialysis services for adults, 2-3 visits per month This code covers dialysis services for patients aged 20 or older who have 2 to 3 physician visits per month. |
98 | $245 | $480 |
| Home dialysis services per month Monthly dialysis treatment provided in the patient's home for individuals aged 20 or older. |
91 | $244 | $480 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
89 | $25 | $75 |
| Hemodialysis, single evaluation A dialysis procedure to filter waste from the blood, performed with a physician's evaluation. |
69 | $58 | $180 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
69 | $41 | $60 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
68 | $51 | $250 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
61 | $142 | $270 |
| Dialysis procedure with evaluation A dialysis treatment that includes one evaluation. |
57 | $72 | $180 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
41 | $25 | $100 |
| Hemoglobin blood test A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen. |
30 | $2 | $10 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
30 | $118 | $300 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
29 | $34 | $150 |
| Red blood cell concentration measurement A laboratory test that measures the concentration of red blood cells in the blood. |
28 | $2 | $30 |
| New patient office visit, 15-29 minutes An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold. |
26 | $34 | $148 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
24 | $32 | $90 |
| Methylprednisolone injection, up to 125 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, with a dosage of up to 125 mg. |
23 | $4 | $15 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $62 | $200 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $28 | $28 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
14 | $72 | $80 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
14 | $19 | $96 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
11 | $10 | $30 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
49.1% high complexity
43.1% medium
7.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$8,400
Total received (2018-2024)
Avg $1,200/year across 7 years
Top 12% in CA for nephrology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
39
Companies
478
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,090
2023
$1,292
2022
$1,516
2021
$1,356
2020
$947
2019
$1,412
2018
$786
Payments by company (2024)
Fresenius USA Marketing, Inc.
$386
Amgen Inc.
$255
Novo Nordisk Inc
$88
CALLIDITAS THERAPEUTICS US INC.
$59
Travere Therapeutics, Inc.
$54
GENZYME CORPORATION
$46
AstraZeneca Pharmaceuticals LP
$40
Mallinckrodt Hospital Products Inc.
$38
OPKO Pharmaceuticals, LLC
$34
Otsuka America Pharmaceutical, Inc.
$24
Chiesi USA, Inc.
$24
GlaxoSmithKline, LLC.
$23
Bayer Healthcare Pharmaceuticals Inc.
$19
Top 3 companies account for 66.9% of 2024 payments
All-time payments by company (2018-2024) ›
Fresenius USA Marketing, Inc.
$1,560
Amgen Inc.
$1,264
Relypsa, Inc.
$793
AstraZeneca Pharmaceuticals LP
$713
Travere Therapeutics, Inc.
$418
OPKO Pharmaceuticals, LLC
$410
Otsuka America Pharmaceutical, Inc.
$366
Vifor Pharma, Inc.
$362
Bayer HealthCare Pharmaceuticals Inc.
$328
GlaxoSmithKline, LLC.
$270
Aurinia Pharma U.S., Inc.
$227
Bayer Healthcare Pharmaceuticals Inc.
$198
Novo Nordisk Inc
$162
Horizon Therapeutics plc
$153
GENZYME CORPORATION
$128
AKEBIA THERAPEUTICS INC
$122
Genentech USA, Inc.
$119
Alexion Pharmaceuticals, Inc.
$101
Mallinckrodt Hospital Products Inc.
$82
Mallinckrodt Enterprises LLC
$75
Daiichi Sankyo Inc.
$72
Allergan Inc.
$59
CALLIDITAS THERAPEUTICS US INC.
$59
AMAG Pharmaceuticals, Inc.
$38
Calliditas Therapeutics US Inc.
$37
BAXTER HEALTHCARE
$31
Shire North American Group Inc
$31
Keryx Biopharmaceuticals, Inc.
$31
Chiesi USA, Inc.
$24
SANOFI-AVENTIS U.S. LLC
$22
Biogen, Inc.
$20
Kyowa Kirin, Inc.
$18
Boehringer Ingelheim Pharmaceuticals, Inc.
$18
Janssen Pharmaceuticals, Inc
$18
Lilly USA, LLC
$17
Hikma Pharmaceuticals USA
$14
Avion Pharmaceuticals
$14
Abbott Laboratories
$13
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$13
Top 3 companies account for 43.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AURYXIA · Aranesp · Auryxia · BENLYSTA · Balcoltra · CardioMEMS HF System · Dialyzers · ELFABRIO · EPOGEN · EVENITY · EVUSHELD · FABRAZYME · FABRY-DISEASE · FARXIGA · FERAHEME · GATTEX · INJECTAFER · INVOKANA · JARDIANCE · JYNARQUE · KRYSTEXXA · Kerendia · LOKELMA · LUPKYNIS · Mitigare · Ozempic · Parsabiv · Prolia · RAYALDEE · RYBELSUS · Rayaldee · Renal - CRRT · Renal - PD · Repatha · Rituxan · Rybelsus · SAMSCA · SOLIQUA 100/33 · SOLIRIS · Soliris · TARPEYO · TEZSPIRE · ULTOMIRIS · VIBERZI · Velphoro · Veltassa · XIFAXAN
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Nephrologists in nearby ZIP areas
10
County median income
$94,486
Nearest hospital to ZIP centroid (approximate)
SALINAS VALLEY MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dicus is a mixed practice specialist, with above-average Medicare volume (top 1% in CA), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dicus experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dicus performed 9,180 iron infusion (feraheme) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Dicus receive payments from pharmaceutical companies?
Yes. Dr. Dicus received a total of $8,400 from 39 companies across 478 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dicus's costs compare to other nephrologists in Salinas?
Dr. Dicus's average Medicare payment per service is $20. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dicus) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Nephrology
Common procedures, typical costs, and what industry payments mean in nephrology.
Same specialty & city
Nephrologists in Salinas
Browse nephrologists in Salinas ranked by procedure volume and transparency data.
Highest volume
Top Nephrologists in CA
Nephrologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Nephrologists in CA
Which CA nephrologists receive the most from drug and device companies.
By company
Fresenius USA Marketing, Inc. Payments to Doctors
See all physicians who received payments from Fresenius USA Marketing, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Relypsa, Inc. Payments to Doctors
See all physicians who received payments from Relypsa, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology